Does URSODIOL Cause Hepatocellular carcinoma? 37 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 37 reports of Hepatocellular carcinoma have been filed in association with URSODIOL (Ursodiol). This represents 1.0% of all adverse event reports for URSODIOL.
37
Reports of Hepatocellular carcinoma with URSODIOL
1.0%
of all URSODIOL reports
2
Deaths
1
Hospitalizations
How Dangerous Is Hepatocellular carcinoma From URSODIOL?
Of the 37 reports, 2 (5.4%) resulted in death, 1 (2.7%) required hospitalization, and 1 (2.7%) were considered life-threatening.
Is Hepatocellular carcinoma Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for URSODIOL. However, 37 reports have been filed with the FAERS database.
What Other Side Effects Does URSODIOL Cause?
Off label use (444)
Drug ineffective (383)
Foetal exposure during pregnancy (262)
Maternal exposure during pregnancy (210)
Pruritus (197)
Premature baby (176)
Exposure during pregnancy (162)
Nausea (149)
Product use in unapproved indication (135)
Death (124)
What Other Drugs Cause Hepatocellular carcinoma?
SORAFENIB (1,665)
RIBAVIRIN (1,046)
SOFOSBUVIR (877)
LEDIPASVIR\SOFOSBUVIR (640)
BEVACIZUMAB (532)
REGORAFENIB (470)
DACLATASVIR (419)
ATEZOLIZUMAB (342)
CABOZANTINIB S-MALATE (219)
TACROLIMUS (183)
Which URSODIOL Alternatives Have Lower Hepatocellular carcinoma Risk?
URSODIOL vs USTEKINUMAB
URSODIOL vs USTEKINUMAB-STBA
URSODIOL vs VADADUSTAT
URSODIOL vs VALACYCLOVIR
URSODIOL vs VALBENAZINE